E-GEOD-6434 - Transcription profiling of human breast tumors resistant or sensitive to docetaxel treatment
Submitted on 4 December 2006, released on 26 October 2007, last updated on 10 June 2011
This SuperSeries is composed of the following subset Series: GSE349: These patients proved resistant to docetaxel treatment, exhibiting residual tumor of 25% or greater remaining volume. Resistant GSE350 These patients were sensitive to docetaxel treatment, exhibiting less than 25% residual tumor.
transcription profiling by array, co-expression, disease state